Latest News

3 March 2016

Depressive symptoms and the risk of Alzheimer’s disease in mild cognitive impairment

University of Tsukuba

According to a community-based longitudinal study in Japan, researchers found that depressive symptoms increased the risk of Alzheimer's disease (AD) in an amnestic mild cognitive impairment (aMCI) group, but not in a non-amnestic mild cognitive impairment (naMCI) group. Likewise, depressive symptoms increased the risk of aMCI but not naMCI in a cognitively normal group. Depressive symptoms might be a clue to finding prodromal AD in patients with a certain type of MCI.

1 March 2016

Dementia: “illness” label can lower mood

University of Exeter

Research led by the University of Exeter looked at people who had recently been diagnosed with dementia, and encountered symptoms such as memory loss, difficulty concentrating or carrying out daily tasks. The study, supported by the Economic Social Research Council and the National Institute for Health Research, and by the European Regional Development Fund, found that people who saw these symptoms as an illness reported lower mood than those who saw it simply as part of the aging process.

11 February 2016

Alzheimer Funding Analyzer Launched on Journal of Alzheimer’s Disease Website

Alzheimer Funding Analyzer

The Journal of Alzheimer’s Disease (JAD) is proud to announce the launch of the Alzheimer’s Funding Analyzer (AFA) on the JAD website. It is a free service that is part of a new suite of online features that have been designed to serve the needs of the Alzheimer disease (AD) research community. AFA presents in-depth data on 115 funders from 42 countries including all of the European Union, Australia, Canada, Ireland, Qatar, the United Kingdom, and the United States.

8 February 2016

Research discovers neuroprotective protein in blood is biomarker of Alzheimer's disease

Tel Aviv University

Tel Aviv University, Harvard, Technion team suggests a routine blood test can reveal Alzheimer's risk and IQ measurements.
Medical professionals have to conduct a long series of tests to assess a patient's memory impairment and cognitive skills, functional abilities, and behavioral changes to accurately diagnose Alzheimer's disease. They also have to execute costly brain imagining scans and even, sometimes, invasive cerebral spinal fluid tests to rule out other diseases. The process is laborious at best -- and subjective at worst.

28 January 2016

Evidence of a lipid link in the inherited form of Alzheimer's disease

Ralph Martins. Photo Credit: Edith Cowan University

Australian researchers have found biochemical changes occurring in the blood, in the rare inherited form of Alzheimer’s disease. Changes in these fat-like substances, may suggest a method to diagnose all forms of Alzheimer’s disease before significant damage to the brain occurs. In an article published today in JAD, the Australian team led by Professor Ralph Martins from the CRC for Mental Health and Edith Cowan University, examined the lipid profiles of 20 people who carry a mutation responsible for the rare inherited form of Alzheimer’s, known as familial Alzheimer’s disease.

20 January 2016

Alzheimer’s Diagnosis Complicated by History of Reading Problems

Brian Lebowitz

Correctly diagnosing Alzheimer’s disease remains a challenge for medical professionals. Now, a new study published in the current issue of the Journal of Alzheimer’s Disease reveals a new clue to possible misdiagnosis. The study found that older adults with a history of reading problems perform similarly on some neuropsychological tests to those who show signs of mild cognitive impairment (MCI) associated with early Alzheimer’s disease. The finding, based on the results of a Stony Brook University-led research team in collaboration with Boston University School of Medicine, emphasizes the need for professionals to take into account developmental history and have a broad understanding of neuropsychological testing when interpreting the meaning of low memory test scores.

18 January 2016

Omega-3 levels affect whether B vitamins can slow brain’s decline

University of Oxford

While research has already established that B vitamin supplements can help slow mental decline in older people with memory problems, an international team have now found that having higher levels of Omega-3 fatty acids in your body could boost the B vitamins’ effect. The team, from the Universities of Cape Town, Oslo, Oxford and the UAE, studied more than 250 people with mild cognitive impairment (MCI) in Oxford. MCI is when brain function is below what is normally expected for a person’s age but is not significant enough to interfere with daily life. While it is not as serious as dementia, if untreated it often progresses to become dementia.

16 December 2015

Link Between Anemia and Mild Cognitive Impairment

Martha Dlugaj

In a large population-based study of randomly selected participants in Germany, researchers found that participants with anemia, defined as haemoglobin less than 13 g/dl in men and less than 12 g/dl in women, showed lower performances in verbal memory and executive functions. Furthermore, mild cognitive impairment (MCI) occurred almost twice more often in participants diagnosed with anemia. This study is published in the Journal of Alzheimer’s Disease.

15 December 2015

Alzheimer’s disease progression linked to changing protein levels in immune system

Martina Sattlecker,

New research has identified changing levels of proteins in the blood which are associated with increasing mental impairment over time in people with Alzheimer's disease. The findings could ultimately help develop new drugs for the condition, by allowing better monitoring of the effects of drugs and improvements in clinical trials.


Subscribe to Latest News